Rational Advisors’s Fortress Biotech FBIO Stock Holding History

Rational Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,962	Closed	-$105K	–	547
2019 Q3	$105K	Buy	+4,962	New	+$117K	0.04%	289

Other funds holding FBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rational Advisors's FBIO Position: Q4 2019 in Review

Rational Advisors sold out of Fortress Biotech (FBIO) in Q4 2019, closing a stake of 4,962 shares — an estimated $105K sold.

Rational Advisors first reported a position in FBIO in Q3 2019 and held it in 1 quarter. The position peaked at $105K in Q3 2019. 54 funds tracked by Wall St. Rank hold FBIO as of Q4 2019.

Rational Advisors reported no remaining Fortress Biotech position as of Q4 2019 after selling out during the quarter.
Rational Advisors sold 4,962 Fortress Biotech shares in Q4 2019, an estimated $105K.
Rational Advisors first reported a position in Fortress Biotech in Q3 2019 and held it in 1 quarter.
Rational Advisors's Fortress Biotech position peaked at $105K in Q3 2019.
54 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2019.

Based on Rational Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.